The Galveston County Daily News, September 29, 2018
Respiratory syncytial virus infect most children younger than 3 years old at some point, which is why UTMB researchers, led by Roberto Garofalo, are working to develop new therapies for RSV. The virus causes mild, cold-like symptoms for some infants and older adults, and can lead to hospitalizations. “We are focusing on RSV now because there is no vaccine or good therapeutic,” Garofalo said.  [See the attached file for the full text of the story.] Texas Medical Center News also covered this research.